1 Research Ethics Infrastructure Challenges in Establishing an Effective System 1 Ruth Macklin, PhD Florencia Luna, PhD.

Slides:



Advertisements
Similar presentations
Alabama Primary Health Care Association
Advertisements

1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
1 Conflicts of interest Different types, different contexts.
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Vilnius, 29 June 2007 CIOMS Recommendations on Ethics in Medical Research The Eighth Global Forum on Bioethics in Research Gottfried Kreutz Dr. med., Dipl.-Chem.;
Plenary Panel: Building an Infrastructure through Training: Best Practices and Lessons Learned from Africa, Asia, Central-Eastern Europe and Latin America.
E. GefenasGlobal Forum 8, June, 2007, Vilnius Regional Perspective to Keynote Challenges - Europe.
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
2 Session Objectives Increase participant understanding of effective financial monitoring based upon risk assessments of sub-grantees Increase participant.
The Implementation Structure DG AGRI, October 2005
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
The Managing Authority –Keystone of the Control System
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
1 Targeted Case Management (TCM) Changes Iowa Medicaid Enterprise October 14, 2008.
What to charge per day? How can I raise my profile? HR Consulting Essentials …Building a sustainable consulting practice How should I present a client.
EMS Checklist (ISO model)
Effective Contract Management Planning
Biopharmaceutical Quality
J Garza Consulting and Associates 1 Pilot Car Escort Certification Model For State Implementation.
AUDIT IN PUBLIC ADMINISTRATION Assoc. Prof. Dr. Recai AKYEL President of the TCA 04 JUNE 2013 TIRANA/ALBANIA.
Office for Human Research Protections 1 Updating the Common Rule Governing Human Subjects Research Protections Jerry Menikoff.
Checking & Corrective Action
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
2 3 There are two basic areas where there is a need to have resources available. Internal:  Financial  Personnel  Assets  Time External  Consultants.
25 seconds left…...
Internal Control and Control Risk
Principles of Standards and Measures
NORMAPME ISO User Guide for European SMEs The essence of.
Good Clinical Practice in Research
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
Keele, 20/07/10 Heike Schmidt-Felzmann Centre of Bioethical Research and Analysis National University of Ireland, Galway Research Ethics in Ireland COBRA.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Good Clinical Practice GCP
Overview of Good Clinical Practices (GCPs)
Internal Auditing and Outsourcing
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Research Ethics Review Malaysian experince Dato Dr. Zaki Morad. Chairperson MREC Dr. Lim TO. Member MREC MOH Malaysia.
Community Paramedic. Benchmark 101 We need a description of the epidemiology of the medical conditions targeted by the community paramedicine program.
1 How to Review a Protocol. 2 Reference Documents WHO/TDR Operational Guidelines for Ethical Committees that Review Biomedical Research, International.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
HUMAN RESEARCH HISTORICAL PERSPECTIVE. Objectives Identify the history events that lead to the development of principles, regulations, and guidance.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Capacity Building in Research Ethics Experiences from Thailand Soraj Hongladarom Department of Philosophy, Chulalongkorn University Bangkok, Thailand.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Other important considerations for RECs Retha Britz.
Ethics Review Committee | 28 th -30 th June 2009, Chengdu 1 |1 | The purpose and process of formal ethical review International Workshop of Ethics Review.
Applicability of principles Reidar K. Lie, MD, PhD Department of Clinical Bioethics, NIH and University of Bergen, Norway.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
GCP (GOOD CLINICAL PRACTISE)
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.
Good Clinical Practice
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Good Clinical Practice in Research
Patient information sheet & Principles of Good Clinical Practice
Presentation transcript:

1 Research Ethics Infrastructure Challenges in Establishing an Effective System 1 Ruth Macklin, PhD Florencia Luna, PhD

2 Capacity building Widespread agreement on need for capacity building in research ethics in developing and transition countries –CIOMS international ethical guidelines –Nuffield Council and NBAC Reports –UNAIDS Vaccine Guidance Document –WHO, NIH, and FIC sponsored workshops But how to determine when capacity is successfully built? 2

3 Settled ethical issues An effective research ethics infrastructure must have –Officially recognized regulations or guidelines governing research with human beings –A system of well-functioning research ethics committees (RECs) –Ethics training for researchers and members of RECs –A system for oversight and monitoring 3

4 Challenges Which international guidelines to use? Who should monitor research, and how? How to ensure adequate ethical review of research protocols? What sort of ethics training is appropriate and adequate? Ongoing problems and controversies 4

5 Regulations and guidelines Many developing countries lack laws or regulations governing ethics in research International guidelines are increasing in number and are not harmonized –Declaration of Helsinki –CIOMS International Ethical Guidelines –ICH GCP –UNESCO Universal Declaration on Bioethics and Human Rights 5

6 Regulations and guidelines Regulations and guidelines require interpretation –Cannot deduce a particular application of a guideline –Example from Declaration of Helsinki At the conclusion of the study, every patient entered into the study should be assured of access to the best proven prophylactic, diagnostic and therapeutic methods identified by the study. –Para. 30 6

7 Regulations and guidelines Guidelines conflict with one another –Multiple and confusing provisions relating to standard of care For participants in control groups in RCTs For participants in prevention trials who acquire the target disease during a clinical trial For participants in any research who develop a treatable disease or condition during the trial –DoH very vague on this point –CIOMS and UNAIDS Guidance disagree 7

8 Ensuring adequate ethical review RECs should have members with expertise in scientific and methodological aspects of research under review –Bad science is bad ethics RECs should clearly indicate which regulations or ethical guidelines they use RECs must have rules of procedure, keep records of proceedings, be accountable 8

9 Ensuring adequate ethical review Desirability of central or regional RECs? Local RECs –Institutional level (hospital based) –Independent but academic based (universities, academic societies) –Independent (for profit) Are for-profit RECs acceptable? –Their client is the sponsor of research but their mandate is to protect human subjects Quality of REC review of research proposals –Avoiding rubberstamping –Avoiding inconsistencies

10 Facilitating ethical review Institutions and governmental agencies should provide financial and administrative support for RECs –Competent secretarial assistance –Photocopying research protocols for distribution to REC members –Communications with investigators –Complete record of REC decisions, progress reports, amendments to protocols 10

11 Ongoing challenges Controversies regarding voluntary vs. professional/paid RECs members Difficulties with voluntary system –Affording protected time –Conflicting demands of job requirements –Recognition of REC service in continuing professional development Preventing REC shopping Confidentiality versus transparency

12 Ongoing challenges Complete follow up of clinical trials and availability of data (publications-bad data) National systems: Sisnep (National system of Information on research ethics involving persons) (Brazil) uusuario.cfm uusuario.cfm Creating a centralized registry of clinical trials – International clinical Trials Registry Platform (WHO)

13 Ethics training Researchers and ERC members should receive ethics training –What sort is adequate or desirable? On-line courses and tests In-person training by experts in research ethics Distribution of the Declaration of Helsinki and other pertinent guidelines or regulations Use of case studies –Total absence of standards or agreement on this issue 13

14 Ongoing challenges Is informal training adequate? Is there a need for official training or standards? Is a system of accreditation of RECs needed? –What would be the standards?

15 Oversight and monitoring Compliance with regulatory authorities for research involving drugs and biotechnology products –European Agency for the Evaluation of Medical Products (EMEA) –U.S. Food and Drug Administration (FDA) –ICH GCP Researchers and RECs must be familiar with these requirements 15

16 Oversight and monitoring Oversight at national or regional level –Some countries have governmental agencies with this responsibility OHRP in U.S. Issues FWAs for other countries –Most developing countries lack any such agency –How to ensure adequacy of REC review and compliance with regulations or guidelines? 16

17 Oversight and monitoring RECs responsible for establishing and maintaining a monitoring system –Adverse event reporting and progress reports –Compliance monitoring necessary to ensure that researchers conduct research properly In compliance with provisions in the protocol In compliance with ethical requirements –Requires a dedicated person knowledgeable about research regulations and ethics –Is time consuming and labor intensive 17

18 Ongoing challenges Informed consent –IC documents provided by industry are overly long, use medical jargon, complex language –Process of obtaining informed consent in conduct of research often flawed, cursory, inadequate understanding by participants –Individual ERCs often not allowed to make changes in consent forms for multicentric trials 18

19 Ongoing challenges Involving communities –Numerous international guidelines refer to community involvement or community participation in the research enterprise Lip service paid to this requirement but little evidence of actual adherence –What forms of community involvement are desirable? Community members on RECs not sufficient –Are there any good models?

20 Ongoing challenges What must RECs review? –Social and behavioral research Not required in some countries or committees Not reviewed even if required –Quality improvement/quality assurance How to distinguish from health systems research? –Public health surveillance or studies in outbreaks How to distinguish from public health research? 20

21 Conflicts of interest What constitutes a genuine conflict of interest in the research setting? –Substantial financial interest on part of researchers or members of RECs –Researchers may not be involved in ethical review of their own protocols Challenges and uncertainties –Members of same academic department, laboratory, or institution as the researcher? 21

22 Controversies regarding money Is it acceptable to pay research subjects for their participation? –Common in some countries, frowned upon in some, prohibited in others –RECs must determine whether and how much Finders fees for recruitment of subjects 22

23 Conclusions Laws, guidelines, and regulations abound –But may conflict with one another –Often do not give clear guidance –May be interpreted differently by RECs RECs are increasingly established in developing countries –Yet reports exist of lack of competency –Hard to obtain information about functioning –General absence of oversight and monitoring 23

24 The way forward Ethical guidelines –No additional ones, please –Can existing ones be harmonized in some way? –Revision and updating needed as things change Declaration of Helsinki and CIOMS, yet controversies remain UNAIDS Guidance for vaccines a new effort 24

25 The way forward Research ethics training and education –More regional workshops needed Train the trainers for in-country capacity building –Educational sessions on research ethics at conferences attended by researchers Industrialized and developing countries Exchange programs and visiting scholars among researchers and REC members –Establishing effective and sustainable research ethics networks in developing countries 25